TM6SF2 and hepatocellular carcinoma: TM6SF2 is shown to facilitate the secretion of TG-rich very low-density lipoproteins (VLDLs), and to a lesser extent, that of apolipoprotein B (APOB) in human hepatoma cell lines [12].